講演・口頭発表等 - 辻　耕平

1. Tsuji K, Huang X, Kobayakawa T, Burke TR Jr., Tamamura H. Development of high-affinity polo-like kinase 1 polo-box domain binding peptides by bivalent approaches. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

2. Shinohara K, Kobayakawa T, Takamatsu Y, Tsuji K, Mitsuya H, Tamamura H. Structure-activity relationship studies of novel SARS-CoV-2 papain-like protease inhibitors and their application as anti-Mpox agents. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

3. Yamamoto K, Kobayakawa T, Tsuji K, Tamamura H. Development of chloroalkene-type dipeptide isosteres for amyloid-beta aggregation inhibitors. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

4. Huang X, Tsuji K, KobayakawaT, Tamamura H. Investigation on degrader peptides targeting the polo-box domain for degradation of polo-like kinase 1. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

5. Miura Y, Tsuji K, Kobayakawa T, Kuwata T, Matsushita S, Tamamura H. Development of antibody drug conjugates as HIV entry inhibitors. 37th European peptide symposium 2024.08.26 Florence

6. Kobayakawa T, Azuma C, Yamamoto K , Tsuji K, Tamamura H. Convergent synthesis of peptidomimetic based on a chloroalkene dipeptide isostere and its application to inhibition against amyloid β aggregation. 14th International Peptide Symposium 2024.08.26 Florence, Italy

7. Miura Y, Tsuji K, Kobayakawa T, Kuwata T, Matsushita S, Tamamura H. Development of hybrid-molecules as HIV entry inhibitors. 18th Chinese international peptide symposium 2024.07.01 Hong Kong

8. Miura Y, Tsuji K, Kobayakawa T, Kuwata T, Matsushita S, Tamamura H. Antibody drug conjugates as HIV entry inhibitors. 27th Korean Peptide Protein Symposium 2024.06.24 Busan

9. 山本 賢一、小早川 拓也、東 知佳、渡邉 優基、辻 耕平、玉村 啓和. アミロイドbeta凝集阻害剤を指向したクロロアルケン型ペプチドミメティックの創製. 日本薬学会第144回年会 2024.03.31 横浜

10. 黒田 悠貴, 小早川 拓也, 辻 耕平, 紺野 奇重, 大橋 南美, 増田 亜美, 三浦 裕太郎, 桑田 岳夫, 吉村 和久, 三浦 智行, 原田 恵嘉, 松下 修三, 玉村 啓和. HIV侵入阻害剤としてのポリエチレングリコールと低分子CD4ミミックのハイブリッド化合物の創製. 日本薬学会第144回年会 2024.03.30 横浜

11. 町田 沙穂, 小早川 拓也, 横山 勝, 藤野 真之, 金子 萌美, 倉上 真樹, 朴 清香, 大西 立人, 小谷 治, 辻 耕平, 村上 努, 佐藤 裕徳, 玉村 啓和. HIV-1カプシドタンパク質の構造を起点とした低分子型抗HIV-1剤の創製. 日本薬学会第144回年会 2024.03.30 横浜

12. 西村 壮史, 小早川 拓也, 辻 耕平, 村上 努, 玉村 啓和. HIV-1外被タンパク質gp41を標的とする二価型膜融合阻害剤の創製. 日本薬学会第144回年会 2024.03.30 横浜

13. 篠原 功紀，鍬田 伸好，辻 耕平，石井 貴大，小早川 拓也，服部 真一朗，岸本 直樹，高宗 暢暁，三隅 将吾，Haydar Bulut，林 宏典，満屋 裕明，玉村 啓和. SARS-CoV-2メインプロテアーゼを標的とした高抗ウイルス活性を有する低分子阻害剤の創製. 日本薬学会第144回年会 2024.03.30 横浜

14. Takuya Kobayakawa, Chika Azuma, Kenichi Yamamoto, Kohei Tsuji, Hirokazu Tamamura. Development of synthetic strategies for peptidomimetic based on a chloroalkene dipeptide isostere and its application to a cyclic peptide. The 15th International Kyoto Conference on New Aspects of Organic Chemistry 2023.11.21 Kyoto

15. Kohei Tsuji, Hirokazu Tamamura, Terrence R. Burke, Jr.. Utilization of a non-specific kinase inhibitor for the development of high-affinity bivalent polo-like kinase 1 polo-box domain inhibitors. The 60th Japanese Peptide Symposium 2023.11.10 Otsu

16. Takuya Kobayakawa, Chika Azuma, Kenichi Yamamoto, Kohei Tsuji, Hirokazu Tamamura. Development of convergent synthesis for peptidomimetic based on a chloroalkene dipeptide isostere and its application to a cyclic peptide. The 60th Japanese Peptide Symposium 2023.11.08 Otsu

17. Kouki Shinohara, Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Yutaro Miura, Chika Azuma, Hironori Hayashi, Shin-ichiro Hattori, Haydar Bulut, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura. Structure-activity relationship studies of novel SARS-CoV-2 main protease inhibitors with potent antiviral activity. The 60th Japanese Peptide Symposium 2023.11.08 Otsu

18. Yutaro Miura, Rongyi Wang, Kohei Tsuji, Yishan Liu, Takuya Kobayakawa, Kazuhisa Yoshimura, Shuzo Matsushita, Shigeyoshi Harada, Hirokazu Tamamura. Combinational use of CD4 mimic with other anti-HIV agents and development of these hybrid molecules. 14th International Peptide Symposium 2023.10.17 Brisbane

19. Yutaro Miura, Rongyi Wang, Kohei Tsuji, Yishan Liu, Takuya Kobayakawa, Kazuhisa Yoshimura, Shuzo Matsushita, Shigeyoshi Harada, Hirokazu Tamamura. Double target inhibitors of HIV-1 entry based on hybrid molecules of CD4 mimics and HIV-1 gp41-related peptides. 26th Korean Peptide Protein Symposium 2023.07.04 Jeju

20. Takahiro Ishii, Kohei Tsuji, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Chika Azuma, Kouki Shinohara, Yutaro Miura, Hironori Hayashi, Haydar Bulut, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura . Design and Synthesis of SARS-CoV-2 Mpro Inhibitors Containing Flurine Atoms and Amide Surrogates. 26th KPPS Annual Symposium 2023.07.03 Jeju